Home › Companies › Bristol-Myers Squibb Company › 2025-2026
Compiled from SEC Form N-PX filings and Bristol-Myers Squibb Company’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore Bristol-Myers Squibb Company in the interactive database Compare manager voting policies
These tallies are Bristol-Myers Squibb Company’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Peter J. Arduini | 1,489,115,718 | 46,952,408 | 2,517,271 | -- | 234,927,659 | Majority: yes |
| Elect Director: Deepak L. Bhatt, M.D., M.P.H., M.B.A. | 1,519,336,832 | 16,821,065 | 2,427,500 | -- | 234,927,659 | Majority: yes |
| Elect Director: Christopher S. Boerner, Ph.D. | 1,462,672,450 | 73,500,542 | 2,412,405 | -- | 234,927,659 | Majority: yes |
| Elect Director: Julia A. Haller, M.D. | 1,513,280,188 | 23,027,628 | 2,277,581 | -- | 234,927,659 | Majority: yes |
| Elect Director: Manuel Hidalgo Medina, M.D., Ph.D. | 1,513,107,431 | 23,055,022 | 2,422,944 | -- | 234,927,659 | Majority: yes |
| Elect Director: Michael R. McMullen | 1,520,590,126 | 15,506,431 | 2,488,840 | -- | 234,927,659 | Majority: yes |
| Elect Director: Paula A. Price | 1,506,560,939 | 29,652,099 | 2,372,359 | -- | 234,927,659 | Majority: yes |
| Elect Director: Derica W. Rice | 1,493,345,909 | 42,806,350 | 2,433,138 | -- | 234,927,659 | Majority: yes |
| Elect Director: Theodore R. Samuels | 1,487,884,432 | 48,111,146 | 2,589,819 | -- | 234,927,659 | Majority: yes |
| Elect Director: Karen H. Vousden, Ph.D. | 1,519,199,326 | 17,078,052 | 2,308,019 | -- | 234,927,659 | Majority: yes |
| Elect Director: Phyllis R. Yale | 1,527,736,604 | 8,485,885 | 2,362,908 | -- | 234,927,659 | Majority: yes |
| Item 2. The management proposal on the advisory vote to approve the compensation of our named executive officers was approved based upon the following votes: | 1,459,162,310 | 72,490,026 | 6,933,061 | -- | 234,927,659 | Majority: yes |
| Item 3. The management proposal on the vote to approve the Company's 2026 stock award and incentive plan was approved based upon the following votes: | 1,470,672,957 | 63,896,918 | 4,015,522 | -- | 234,927,659 | Majority: yes |
| Item 4. The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for 2026 was ratified based upon the following votes: | 1,706,279,839 | 63,727,901 | 3,505,316 | -- | -- | Majority: yes |
| Item 5. The shareholder proposal on the adoption of a board policy that the chairperson of the board be an independent director was not approved based upon the following votes: | 422,069,323 | 1,109,378,680 | 7,137,394 | -- | 234,927,659 | Majority: no |
Source: Bristol-Myers Squibb Company, Form 8-K — read the filing on EDGAR.
Each item below shows how the 1,530 asset managers that disclosed a Bristol-Myers Squibb Company vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Bristol-Myers Squibb Company’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2026-05-05.
Combines 40 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Item 2. The management proposal on the advisory vote to approve the compensation of our named executive officers was approved based upon the following votes:”): 1,459,162,310 for, 72,490,026 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 71% for, 4% against (75% of the company cast a for/against vote).
The 1,503 asset managers below cast 97% of the shares they voted on this item FOR (1,413,898,771 for, 46,618,028 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 232,524,611 | 1,047 | 104 | 0 | For |
| Charles Schwab | 149,004,146 | 0 | 0 | 0 | For |
| BlackRock | 145,123,802 | 8,302 | 0 | 0 | For |
| Fidelity | 65,403,594 | 0 | 0 | 0 | For |
| State Street | 62,699,854 | 126,047 | 52,277 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 54,460,957 | 0 | 0 | 0 | For |
| JPMorgan | 42,434,961 | 0 | 0 | 0 | For |
| Invesco | 32,737,014 | 60 | 6 | 0 | For |
| PRIMECAP MANAGEMENT CO/CA/ | 24,901,600 | 0 | 0 | 0 | For |
| Capital Group | 20,471,968 | 0 | 0 | 0 | For |
| Northern Trust | 20,285,011 | 0 | 0 | 0 | For |
| Independent Franchise Partners LLP | 19,108,235 | 0 | 0 | 0 | For |
| AQR | 17,022,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 16,459,012 | 0 | 0 | 0 | For |
| PZENA INVESTMENT MANAGEMENT LLC | 15,890,340 | 0 | 0 | 0 | For |
| Amundi | 14,994,285 | 53,195 | 0 | 0 | For |
| Columbia Threadneedle | 14,414,278 | 0 | 0 | 0 | For |
| UBS | 13,821,159 | 0 | 0 | 0 | For |
| Dimensional | 12,894,324 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 229,938 | 10,384,992 | 26,138 | 0 | Against |
| MELLON INVESTMENTS Corp | 10,367,175 | 0 | 0 | 0 | For |
| Victory Capital | 9,883,312 | 0 | 0 | 0 | For |
| Dodge & Cox | 8,690,918 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 8,293,887 | 0 | 0 | 0 | For |
| Goldman Sachs | 8,139,084 | 0 | 0 | 0 | For |
Showing the 25 largest of 1,503 asset managers. See all 1,503 in the interactive database.
Meeting held 2026-05-05.
Combines 12 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Item 3. The management proposal on the vote to approve the Company's 2026 stock award and incentive plan was approved based upon the following votes:”): 1,470,672,957 for, 63,896,918 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 72% for, 3% against (75% of the company cast a for/against vote).
The 254 asset managers below cast 99.8% of the shares they voted on this item FOR (603,633,589 for, 1,013,924 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 211,063,443 | 963 | 58 | 0 | For |
| Charles Schwab | 74,274,455 | 0 | 0 | 0 | For |
| BlackRock | 54,345,917 | 0 | 0 | 0 | For |
| Fidelity | 54,066,555 | 0 | 0 | 0 | For |
| JPMorgan | 36,649,001 | 0 | 0 | 0 | For |
| State Street | 24,253,110 | 0 | 0 | 0 | For |
| Invesco | 14,483,429 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 14,132,656 | 0 | 0 | 0 | For |
| Capital Group | 9,766,541 | 0 | 0 | 0 | For |
| Dimensional | 9,232,561 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 8,293,887 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 7,387,593 | 0 | 0 | 0 | For |
| First Trust | 5,258,387 | 0 | 0 | 0 | For |
| TIAA | 4,521,603 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,838,745 | 0 | 0 | 0 | For |
| Jackson National | 3,785,976 | 0 | 0 | 0 | For |
| Victory Capital | 3,718,111 | 0 | 0 | 0 | For |
| Dodge & Cox | 3,635,139 | 0 | 0 | 0 | For |
| BNY Mellon | 3,308,959 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 3,177,769 | 0 | 0 | 0 | For |
| Eaton Vance | 2,214,633 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,991,140 | 0 | 0 | 0 | For |
| Equitable | 1,988,044 | 0 | 0 | 0 | For |
| Advisers Investment Trust | 1,899,874 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,730,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 254 asset managers. See all 254 in the interactive database.
Meeting held 2026-05-05.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Item 4. The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for 2026 was ratified based upon the following votes:”): 1,706,279,839 for, 63,727,901 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 84% for, 3% against (87% of the company cast a for/against vote).
The 234 asset managers below cast 99.8% of the shares they voted on this item FOR (603,294,083 for, 734,520 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 210,877,420 | 187,013 | 30 | 0 | For |
| Charles Schwab | 74,274,455 | 0 | 0 | 0 | For |
| BlackRock | 54,334,224 | 11,693 | 0 | 0 | For |
| Fidelity | 54,066,555 | 0 | 0 | 0 | For |
| JPMorgan | 36,649,001 | 0 | 0 | 0 | For |
| State Street | 24,252,573 | 537 | 0 | 0 | For |
| Invesco | 14,483,429 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 14,132,656 | 0 | 0 | 0 | For |
| Capital Group | 9,766,541 | 0 | 0 | 0 | For |
| Dimensional | 9,232,561 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 8,293,887 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 7,387,593 | 0 | 0 | 0 | For |
| First Trust | 5,258,387 | 0 | 0 | 0 | For |
| TIAA | 4,521,603 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,838,745 | 0 | 0 | 0 | For |
| Jackson National | 3,785,976 | 0 | 0 | 0 | For |
| Victory Capital | 3,718,111 | 0 | 0 | 0 | For |
| Dodge & Cox | 3,635,139 | 0 | 0 | 0 | For |
| BNY Mellon | 3,308,959 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 3,177,769 | 0 | 0 | 0 | For |
| Eaton Vance | 2,214,633 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,991,140 | 0 | 0 | 0 | For |
| Equitable | 1,988,044 | 0 | 0 | 0 | For |
| Advisers Investment Trust | 1,899,874 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,730,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 234 asset managers. See all 234 in the interactive database.
Meeting held 2026-05-05.
Combines 7 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Peter J. Arduini”): 1,489,115,718 for, 46,952,408 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 73% for, 2% against (75% of the company cast a for/against vote).
The 229 asset managers below cast 99.8% of the shares they voted on this item FOR (602,808,140 for, 1,150,761 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 210,728,854 | 335,574 | 38 | 0 | For |
| Charles Schwab | 74,274,455 | 0 | 0 | 0 | For |
| BlackRock | 54,310,353 | 35,564 | 0 | 0 | For |
| Fidelity | 54,066,555 | 0 | 0 | 0 | For |
| JPMorgan | 36,649,001 | 0 | 0 | 0 | For |
| State Street | 24,207,542 | 0 | 45,568 | 0 | For |
| Invesco | 14,483,429 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 14,132,656 | 0 | 0 | 0 | For |
| Capital Group | 9,766,541 | 0 | 0 | 0 | For |
| Dimensional | 9,232,561 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 8,293,887 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 7,387,593 | 0 | 0 | 0 | For |
| First Trust | 5,258,387 | 0 | 0 | 0 | For |
| TIAA | 4,521,603 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,838,745 | 0 | 0 | 0 | For |
| Jackson National | 3,785,976 | 0 | 0 | 0 | For |
| Victory Capital | 3,718,111 | 0 | 0 | 0 | For |
| Dodge & Cox | 3,635,139 | 0 | 0 | 0 | For |
| BNY Mellon | 3,308,959 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 3,177,769 | 0 | 0 | 0 | For |
| Eaton Vance | 2,214,633 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,991,140 | 0 | 0 | 0 | For |
| Equitable | 1,988,044 | 0 | 0 | 0 | For |
| Advisers Investment Trust | 1,899,874 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,730,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.
Meeting held 2026-05-05.
Combines 10 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Deepak L. Bhatt, M.D., M.P.H., M.B.A.”): 1,519,336,832 for, 16,821,065 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 74% for, 0.9% against (75% of the company cast a for/against vote).
The 229 asset managers below cast 99.9% of the shares they voted on this item FOR (603,567,071 for, 391,829 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 210,729,321 | 335,107 | 36 | 0 | For |
| Charles Schwab | 74,274,455 | 0 | 0 | 0 | For |
| BlackRock | 54,345,917 | 0 | 0 | 0 | For |
| Fidelity | 54,066,555 | 0 | 0 | 0 | For |
| JPMorgan | 36,649,001 | 0 | 0 | 0 | For |
| State Street | 24,207,542 | 0 | 45,568 | 0 | For |
| Invesco | 14,483,429 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 14,132,656 | 0 | 0 | 0 | For |
| Capital Group | 9,766,541 | 0 | 0 | 0 | For |
| Dimensional | 9,232,561 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 8,293,887 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 7,387,593 | 0 | 0 | 0 | For |
| First Trust | 5,258,387 | 0 | 0 | 0 | For |
| TIAA | 4,521,603 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,838,745 | 0 | 0 | 0 | For |
| Jackson National | 3,785,976 | 0 | 0 | 0 | For |
| Victory Capital | 3,718,111 | 0 | 0 | 0 | For |
| Dodge & Cox | 3,635,139 | 0 | 0 | 0 | For |
| BNY Mellon | 3,308,959 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 3,177,769 | 0 | 0 | 0 | For |
| Eaton Vance | 2,214,633 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,991,140 | 0 | 0 | 0 | For |
| Equitable | 1,988,044 | 0 | 0 | 0 | For |
| Advisers Investment Trust | 1,899,874 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,730,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.
Meeting held 2026-05-05.
Combines 9 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Christopher S. Boerner, Ph.D.”): 1,462,672,450 for, 73,500,542 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 72% for, 4% against (75% of the company cast a for/against vote).
The 229 asset managers below cast 99.9% of the shares they voted on this item FOR (603,906,550 for, 97,919 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 211,063,480 | 948 | 36 | 0 | For |
| Charles Schwab | 74,274,455 | 0 | 0 | 0 | For |
| BlackRock | 54,345,917 | 0 | 0 | 0 | For |
| Fidelity | 54,066,555 | 0 | 0 | 0 | For |
| JPMorgan | 36,649,001 | 0 | 0 | 0 | For |
| State Street | 24,252,840 | 270 | 0 | 0 | For |
| Invesco | 14,483,429 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 14,132,656 | 0 | 0 | 0 | For |
| Capital Group | 9,766,541 | 0 | 0 | 0 | For |
| Dimensional | 9,232,561 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 8,293,887 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 7,387,593 | 0 | 0 | 0 | For |
| First Trust | 5,258,387 | 0 | 0 | 0 | For |
| TIAA | 4,521,603 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,838,745 | 0 | 0 | 0 | For |
| Jackson National | 3,785,976 | 0 | 0 | 0 | For |
| Victory Capital | 3,718,111 | 0 | 0 | 0 | For |
| Dodge & Cox | 3,635,139 | 0 | 0 | 0 | For |
| BNY Mellon | 3,308,959 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 3,177,769 | 0 | 0 | 0 | For |
| Eaton Vance | 2,214,633 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,991,140 | 0 | 0 | 0 | For |
| Equitable | 1,956,589 | 31,455 | 0 | 0 | For |
| Advisers Investment Trust | 1,899,874 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,730,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.
Meeting held 2026-05-05.
Combines 10 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Julia A. Haller, M.D.”): 1,513,280,188 for, 23,027,628 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 74% for, 1% against (75% of the company cast a for/against vote).
The 229 asset managers below cast 99.9% of the shares they voted on this item FOR (603,566,978 for, 391,925 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 210,729,228 | 335,203 | 33 | 0 | For |
| Charles Schwab | 74,274,455 | 0 | 0 | 0 | For |
| BlackRock | 54,345,917 | 0 | 0 | 0 | For |
| Fidelity | 54,066,555 | 0 | 0 | 0 | For |
| JPMorgan | 36,649,001 | 0 | 0 | 0 | For |
| State Street | 24,207,542 | 0 | 45,568 | 0 | For |
| Invesco | 14,483,429 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 14,132,656 | 0 | 0 | 0 | For |
| Capital Group | 9,766,541 | 0 | 0 | 0 | For |
| Dimensional | 9,232,561 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 8,293,887 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 7,387,593 | 0 | 0 | 0 | For |
| First Trust | 5,258,387 | 0 | 0 | 0 | For |
| TIAA | 4,521,603 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,838,745 | 0 | 0 | 0 | For |
| Jackson National | 3,785,976 | 0 | 0 | 0 | For |
| Victory Capital | 3,718,111 | 0 | 0 | 0 | For |
| Dodge & Cox | 3,635,139 | 0 | 0 | 0 | For |
| BNY Mellon | 3,308,959 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 3,177,769 | 0 | 0 | 0 | For |
| Eaton Vance | 2,214,633 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,991,140 | 0 | 0 | 0 | For |
| Equitable | 1,988,044 | 0 | 0 | 0 | For |
| Advisers Investment Trust | 1,899,874 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,730,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.
Meeting held 2026-05-05.
Combines 11 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Manuel Hidalgo Medina, M.D., Ph.D.”): 1,513,107,431 for, 23,055,022 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 74% for, 1% against (75% of the company cast a for/against vote).
The 229 asset managers below cast 99.9% of the shares they voted on this item FOR (603,566,975 for, 391,925 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 210,729,225 | 335,203 | 36 | 0 | For |
| Charles Schwab | 74,274,455 | 0 | 0 | 0 | For |
| BlackRock | 54,345,917 | 0 | 0 | 0 | For |
| Fidelity | 54,066,555 | 0 | 0 | 0 | For |
| JPMorgan | 36,649,001 | 0 | 0 | 0 | For |
| State Street | 24,207,542 | 0 | 45,568 | 0 | For |
| Invesco | 14,483,429 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 14,132,656 | 0 | 0 | 0 | For |
| Capital Group | 9,766,541 | 0 | 0 | 0 | For |
| Dimensional | 9,232,561 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 8,293,887 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 7,387,593 | 0 | 0 | 0 | For |
| First Trust | 5,258,387 | 0 | 0 | 0 | For |
| TIAA | 4,521,603 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,838,745 | 0 | 0 | 0 | For |
| Jackson National | 3,785,976 | 0 | 0 | 0 | For |
| Victory Capital | 3,718,111 | 0 | 0 | 0 | For |
| Dodge & Cox | 3,635,139 | 0 | 0 | 0 | For |
| BNY Mellon | 3,308,959 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 3,177,769 | 0 | 0 | 0 | For |
| Eaton Vance | 2,214,633 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,991,140 | 0 | 0 | 0 | For |
| Equitable | 1,988,044 | 0 | 0 | 0 | For |
| Advisers Investment Trust | 1,899,874 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,730,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.
Meeting held 2026-05-05.
Combines 8 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Michael R. McMullen”): 1,520,590,126 for, 15,506,431 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 74% for, 0.8% against (75% of the company cast a for/against vote).
The 229 asset managers below cast 99.9% of the shares they voted on this item FOR (603,955,168 for, 49,300 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 211,064,189 | 238 | 37 | 0 | For |
| Charles Schwab | 74,274,455 | 0 | 0 | 0 | For |
| BlackRock | 54,345,917 | 0 | 0 | 0 | For |
| Fidelity | 54,066,555 | 0 | 0 | 0 | For |
| JPMorgan | 36,649,001 | 0 | 0 | 0 | For |
| State Street | 24,253,110 | 0 | 0 | 0 | For |
| Invesco | 14,483,429 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 14,132,656 | 0 | 0 | 0 | For |
| Capital Group | 9,766,541 | 0 | 0 | 0 | For |
| Dimensional | 9,232,561 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 8,293,887 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 7,387,593 | 0 | 0 | 0 | For |
| First Trust | 5,258,387 | 0 | 0 | 0 | For |
| TIAA | 4,521,603 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,838,745 | 0 | 0 | 0 | For |
| Jackson National | 3,785,976 | 0 | 0 | 0 | For |
| Victory Capital | 3,718,111 | 0 | 0 | 0 | For |
| Dodge & Cox | 3,635,139 | 0 | 0 | 0 | For |
| BNY Mellon | 3,308,959 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 3,177,769 | 0 | 0 | 0 | For |
| Eaton Vance | 2,214,633 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,991,140 | 0 | 0 | 0 | For |
| Equitable | 1,988,044 | 0 | 0 | 0 | For |
| Advisers Investment Trust | 1,899,874 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,730,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.
Meeting held 2026-05-05.
Combines 7 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Paula A. Price”): 1,506,560,939 for, 29,652,099 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 74% for, 1% against (75% of the company cast a for/against vote).
The 229 asset managers below cast 99.9% of the shares they voted on this item FOR (603,566,928 for, 391,971 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 210,729,178 | 335,249 | 35 | 0 | For |
| Charles Schwab | 74,274,455 | 0 | 0 | 0 | For |
| BlackRock | 54,345,917 | 0 | 0 | 0 | For |
| Fidelity | 54,066,555 | 0 | 0 | 0 | For |
| JPMorgan | 36,649,001 | 0 | 0 | 0 | For |
| State Street | 24,207,542 | 0 | 45,568 | 0 | For |
| Invesco | 14,483,429 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 14,132,656 | 0 | 0 | 0 | For |
| Capital Group | 9,766,541 | 0 | 0 | 0 | For |
| Dimensional | 9,232,561 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 8,293,887 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 7,387,593 | 0 | 0 | 0 | For |
| First Trust | 5,258,387 | 0 | 0 | 0 | For |
| TIAA | 4,521,603 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,838,745 | 0 | 0 | 0 | For |
| Jackson National | 3,785,976 | 0 | 0 | 0 | For |
| Victory Capital | 3,718,111 | 0 | 0 | 0 | For |
| Dodge & Cox | 3,635,139 | 0 | 0 | 0 | For |
| BNY Mellon | 3,308,959 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 3,177,769 | 0 | 0 | 0 | For |
| Eaton Vance | 2,214,633 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,991,140 | 0 | 0 | 0 | For |
| Equitable | 1,988,044 | 0 | 0 | 0 | For |
| Advisers Investment Trust | 1,899,874 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,730,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.
Meeting held 2026-05-05.
Combines 7 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Derica W. Rice”): 1,493,345,909 for, 42,806,350 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 73% for, 2% against (75% of the company cast a for/against vote).
The 229 asset managers below cast 99.1% of the shares they voted on this item FOR (598,827,634 for, 5,131,266 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 206,122,919 | 4,941,509 | 36 | 0 | For |
| Charles Schwab | 74,274,455 | 0 | 0 | 0 | For |
| BlackRock | 54,345,917 | 0 | 0 | 0 | For |
| Fidelity | 54,066,555 | 0 | 0 | 0 | For |
| JPMorgan | 36,649,001 | 0 | 0 | 0 | For |
| State Street | 24,207,542 | 0 | 45,568 | 0 | For |
| Invesco | 14,483,429 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 14,132,656 | 0 | 0 | 0 | For |
| Capital Group | 9,766,541 | 0 | 0 | 0 | For |
| Dimensional | 9,232,561 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 8,293,887 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 7,387,593 | 0 | 0 | 0 | For |
| First Trust | 5,258,387 | 0 | 0 | 0 | For |
| TIAA | 4,521,603 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,838,745 | 0 | 0 | 0 | For |
| Jackson National | 3,785,976 | 0 | 0 | 0 | For |
| Victory Capital | 3,716,910 | 1,201 | 0 | 0 | For |
| Dodge & Cox | 3,635,139 | 0 | 0 | 0 | For |
| BNY Mellon | 3,308,959 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 3,177,769 | 0 | 0 | 0 | For |
| Eaton Vance | 2,214,633 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,991,140 | 0 | 0 | 0 | For |
| Equitable | 1,988,044 | 0 | 0 | 0 | For |
| Advisers Investment Trust | 1,899,874 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,730,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.
Meeting held 2026-05-05.
Combines 7 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Theodore R. Samuels”): 1,487,884,432 for, 48,111,146 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 73% for, 2% against (75% of the company cast a for/against vote).
The 229 asset managers below cast 99.8% of the shares they voted on this item FOR (602,793,657 for, 1,165,242 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 210,542,846 | 521,581 | 38 | 0 | For |
| Charles Schwab | 74,274,455 | 0 | 0 | 0 | For |
| BlackRock | 54,334,224 | 11,693 | 0 | 0 | For |
| Fidelity | 54,066,555 | 0 | 0 | 0 | For |
| JPMorgan | 36,649,001 | 0 | 0 | 0 | For |
| State Street | 24,207,542 | 0 | 45,568 | 0 | For |
| Invesco | 14,483,429 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 14,132,656 | 0 | 0 | 0 | For |
| Capital Group | 9,766,541 | 0 | 0 | 0 | For |
| Dimensional | 9,232,561 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 8,293,887 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 7,387,593 | 0 | 0 | 0 | For |
| First Trust | 5,258,387 | 0 | 0 | 0 | For |
| TIAA | 4,521,603 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,838,745 | 0 | 0 | 0 | For |
| Jackson National | 3,785,976 | 0 | 0 | 0 | For |
| Victory Capital | 3,718,111 | 0 | 0 | 0 | For |
| Dodge & Cox | 3,635,139 | 0 | 0 | 0 | For |
| BNY Mellon | 3,308,959 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 3,177,769 | 0 | 0 | 0 | For |
| Eaton Vance | 2,214,633 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,991,140 | 0 | 0 | 0 | For |
| Equitable | 1,988,044 | 0 | 0 | 0 | For |
| Advisers Investment Trust | 1,899,874 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,730,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.
Meeting held 2026-05-05.
Combines 9 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Karen H. Vousden, Ph.D.”): 1,519,199,326 for, 17,078,052 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 74% for, 0.9% against (75% of the company cast a for/against vote).
The 229 asset managers below cast 99.9% of the shares they voted on this item FOR (603,567,069 for, 391,833 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 210,729,319 | 335,111 | 35 | 0 | For |
| Charles Schwab | 74,274,455 | 0 | 0 | 0 | For |
| BlackRock | 54,345,917 | 0 | 0 | 0 | For |
| Fidelity | 54,066,555 | 0 | 0 | 0 | For |
| JPMorgan | 36,649,001 | 0 | 0 | 0 | For |
| State Street | 24,207,542 | 0 | 45,568 | 0 | For |
| Invesco | 14,483,429 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 14,132,656 | 0 | 0 | 0 | For |
| Capital Group | 9,766,541 | 0 | 0 | 0 | For |
| Dimensional | 9,232,561 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 8,293,887 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 7,387,593 | 0 | 0 | 0 | For |
| First Trust | 5,258,387 | 0 | 0 | 0 | For |
| TIAA | 4,521,603 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,838,745 | 0 | 0 | 0 | For |
| Jackson National | 3,785,976 | 0 | 0 | 0 | For |
| Victory Capital | 3,718,111 | 0 | 0 | 0 | For |
| Dodge & Cox | 3,635,139 | 0 | 0 | 0 | For |
| BNY Mellon | 3,308,959 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 3,177,769 | 0 | 0 | 0 | For |
| Eaton Vance | 2,214,633 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,991,140 | 0 | 0 | 0 | For |
| Equitable | 1,988,044 | 0 | 0 | 0 | For |
| Advisers Investment Trust | 1,899,874 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,730,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.
Meeting held 2026-05-05.
Combines 8 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Phyllis R. Yale”): 1,527,736,604 for, 8,485,885 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 75% for, 0.5% against (75% of the company cast a for/against vote).
The 229 asset managers below cast 99.9% of the shares they voted on this item FOR (603,567,201 for, 391,699 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 210,729,451 | 334,977 | 35 | 0 | For |
| Charles Schwab | 74,274,455 | 0 | 0 | 0 | For |
| BlackRock | 54,345,917 | 0 | 0 | 0 | For |
| Fidelity | 54,066,555 | 0 | 0 | 0 | For |
| JPMorgan | 36,649,001 | 0 | 0 | 0 | For |
| State Street | 24,207,542 | 0 | 45,568 | 0 | For |
| Invesco | 14,483,429 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 14,132,656 | 0 | 0 | 0 | For |
| Capital Group | 9,766,541 | 0 | 0 | 0 | For |
| Dimensional | 9,232,561 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 8,293,887 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 7,387,593 | 0 | 0 | 0 | For |
| First Trust | 5,258,387 | 0 | 0 | 0 | For |
| TIAA | 4,521,603 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,838,745 | 0 | 0 | 0 | For |
| Jackson National | 3,785,976 | 0 | 0 | 0 | For |
| Victory Capital | 3,718,111 | 0 | 0 | 0 | For |
| Dodge & Cox | 3,635,139 | 0 | 0 | 0 | For |
| BNY Mellon | 3,308,959 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 3,177,769 | 0 | 0 | 0 | For |
| Eaton Vance | 2,214,633 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,991,140 | 0 | 0 | 0 | For |
| Equitable | 1,988,044 | 0 | 0 | 0 | For |
| Advisers Investment Trust | 1,899,874 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,730,775 | 0 | 0 | 0 | For |
Showing the 25 largest of 229 asset managers. See all 229 in the interactive database.
Meeting held 2026-05-05.
Combines 3 wordings of this item as funds reported it.
28% Majority: no · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Item 5. The shareholder proposal on the adoption of a board policy that the chairperson of the board be an independent director was not approved based upon the following votes:”): 422,069,323 for, 1,109,378,680 against, per its Form 8-K (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 21% for, 54.3% against (75% of the company cast a for/against vote).
The 219 asset managers below cast 8% of the shares they voted on this item FOR (48,771,475 for, 552,681,827 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,744,038 | 205,320,328 | 99 | 0 | Against |
| Charles Schwab | 3,479 | 74,270,976 | 0 | 0 | Against |
| BlackRock | 59,176 | 54,286,741 | 0 | 0 | Against |
| Fidelity | 757,765 | 53,308,790 | 0 | 0 | Against |
| JPMorgan | 0 | 36,649,001 | 0 | 0 | Against |
| State Street | 8,067 | 24,245,043 | 0 | 0 | Against |
| Invesco | 0 | 14,483,429 | 0 | 0 | Against |
| Columbia Threadneedle | 14,132,656 | 0 | 0 | 0 | For |
| Capital Group | 9,766,541 | 0 | 0 | 0 | For |
| Dimensional | 0 | 9,232,561 | 0 | 0 | Against |
| Pacer Funds Trust | 0 | 8,293,887 | 0 | 0 | Against |
| VanEck ETF Trust | 7,387,593 | 0 | 0 | 0 | For |
| First Trust | 0 | 5,258,387 | 0 | 0 | Against |
| TIAA | 0 | 4,521,603 | 0 | 0 | Against |
| T. Rowe Price | 0 | 3,838,745 | 0 | 0 | Against |
| Jackson National | 0 | 3,785,976 | 0 | 0 | Against |
| Victory Capital | 1,201 | 3,716,910 | 0 | 0 | Against |
| Dodge & Cox | 0 | 3,635,139 | 0 | 0 | Against |
| BNY Mellon | 0 | 3,308,959 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 0 | 3,177,769 | 0 | 0 | Against |
| Eaton Vance | 0 | 2,214,633 | 0 | 0 | Against |
| PRIMECAP Odyssey Funds | 0 | 1,991,140 | 0 | 0 | Against |
| Equitable | 31,455 | 1,956,589 | 0 | 0 | Against |
| Advisers Investment Trust | 1,548,874 | 351,000 | 0 | 0 | For |
| Six Circles Trust | 0 | 1,730,775 | 0 | 0 | Against |
Showing the 25 largest of 219 asset managers. See all 219 in the interactive database.
Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Item 2. The management proposal on the advisory vote to approve the compensation of our named executive officers was approved based upon the following votes:”): 1,443,673,104 for, 92,005,419 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 71% for, 5% against (75% of the company cast a for/against vote).
The 10 asset managers below cast 100% of the shares they voted on this item FOR (1,068,505 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Investment Management Corp of Ontario | 511,209 | 0 | 0 | 0 | For |
| OSSIAM | 258,878 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 146,947 | 0 | 0 | 0 | For |
| OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC | 83,748 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 40,900 | 0 | 0 | 0 | For |
| PENSIOENFONDS RAIL & OV | 16,800 | 0 | 0 | 0 | For |
| FIRST UNITED BANK & TRUST | 6,052 | 0 | 0 | 0 | For |
| Philip James Wealth Mangement, LLC | 2,796 | 0 | 0 | 0 | For |
| NORRIS PERNE & FRENCH LLP/MI | 1,175 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Meeting held 2026-05-05.
20% fund support · no official result
The 8 asset managers below cast 20% of the shares they voted on this item FOR (213,988 for, 853,387 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 0 | 411,196 | 0 | 0 | Against |
| Brighthouse | 0 | 272,178 | 0 | 0 | Against |
| Erste Asset Management GmbH | 137,744 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 116,419 | 0 | 0 | Against |
| GreenFi Funds Trust | 50,812 | 0 | 0 | 0 | For |
| OARSMAN CAPITAL, INC. | 0 | 29,558 | 0 | 0 | Against |
| AGF Investments Trust | 25,432 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 24,036 | 0 | 0 | Against |
Meeting held 2026-05-05.
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% fund support · no official result
The 5 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HARBOUR INVESTMENT MANAGEMENT LLC | 245,168 | 0 | 0 | 0 | For |
| McGowan Group Asset Management, Inc. | 1,002 | 0 | 0 | 0 | For |
| ESL Trust Services, LLC | 700 | 0 | 0 | 0 | For |
| TEALWOOD ASSET MANAGEMENT INC | 100 | 0 | 0 | 0 | For |
| Williamson Legacy Group, LLC | 40 | 0 | 0 | 0 | For |
Meeting held 2026-05-05.
0.2% fund support · no official result
The 5 asset managers below cast 0.2% of the shares they voted on this item FOR (40 for, 24,090 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HARBOUR INVESTMENT MANAGEMENT LLC | 0 | 22,288 | 0 | 0 | Against |
| McGowan Group Asset Management, Inc. | 0 | 1,002 | 0 | 0 | Against |
| ESL Trust Services, LLC | 0 | 700 | 0 | 0 | Against |
| TEALWOOD ASSET MANAGEMENT INC | 0 | 100 | 0 | 0 | Against |
| Williamson Legacy Group, LLC | 40 | 0 | 0 | 0 | For |
Meeting held 2026-05-05.
28% Majority: no · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Item 5. The shareholder proposal on the adoption of a board policy that the chairperson of the board be an independent director was not approved based upon the following votes:”): 422,069,323 for, 1,109,378,680 against, per its Form 8-K (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 21% for, 54.3% against (75% of the company cast a for/against vote).
The 5 asset managers below cast 99.9% of the shares they voted on this item FOR (1,401,987 for, 165 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Cardano Risk Management B.V. | 1,278,638 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 77,200 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 46,039 | 0 | 0 | 0 | For |
| Rockport Wealth LLC | 0 | 165 | 0 | 0 | Against |
| PACE SELECT ADVISORS TRUST | 110 | 0 | 0 | 0 | For |
Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Christopher S. Boerner, Ph.D.”): 1,428,210,815 for, 110,402,978 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 70% for, 5% against (75% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (187,847 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLENMEDE FUND INC | 146,947 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 40,900 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Deepak L. Bhatt, M.D., M.P.H., M.B.A.”): 1,532,130,327 for, 6,515,446 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 75% for, 0.4% against (75% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (187,847 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLENMEDE FUND INC | 146,947 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 40,900 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Derica W. Rice”): 1,490,843,764 for, 47,794,410 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 73% for, 2% against (75% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (187,847 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLENMEDE FUND INC | 146,947 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 40,900 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Julia A. Haller, M.D.”): 1,528,545,297 for, 10,278,914 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 75% for, 0.6% against (75% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (187,847 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLENMEDE FUND INC | 146,947 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 40,900 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Karen H. Vousden, Ph.D.”): 1,532,436,948 for, 6,272,241 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 75% for, 0.4% against (75% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (187,847 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLENMEDE FUND INC | 146,947 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 40,900 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Manuel Hidalgo Medina, M.D., Ph.D.”): 1,528,499,927 for, 10,124,822 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 75% for, 0.5% against (75% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (187,847 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLENMEDE FUND INC | 146,947 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 40,900 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Michael R. McMullen”): 1,533,441,518 for, 5,010,614 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 75% for, 0.3% against (75% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (187,847 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLENMEDE FUND INC | 146,947 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 40,900 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Paula A. Price”): 1,521,414,163 for, 17,093,785 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 75% for, 0.9% against (75% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (187,847 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLENMEDE FUND INC | 146,947 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 40,900 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Peter J. Arduini”): 1,514,455,481 for, 24,103,012 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 74% for, 1% against (75% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (187,847 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLENMEDE FUND INC | 146,947 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 40,900 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Phyllis R. Yale”): 1,532,047,920 for, 6,606,486 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 75% for, 0.4% against (75% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (187,847 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLENMEDE FUND INC | 146,947 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 40,900 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Elect Director: Theodore R. Samuels”): 1,515,155,910 for, 23,349,581 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 74% for, 1% against (75% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (187,847 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLENMEDE FUND INC | 146,947 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 40,900 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Item 3. The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for 2025 was ratified based upon the following votes:”): 1,720,056,974 for, 59,373,345 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 84% for, 3% against (87% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (187,847 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLENMEDE FUND INC | 146,947 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 40,900 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
1% Majority: no · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Item 4. The shareholder proposal on Corporate Financial Sustainability was not approved based upon the following votes:”): 17,608,619 for, 1,510,021,361 against, per its Form 8-K (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 0.9% for, 74% against (75% of the company cast a for/against vote).
The 3 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 187,847 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLENMEDE FUND INC | 0 | 146,947 | 0 | 0 | Against |
| Ultimus Managers Trust | 0 | 40,900 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
2% Majority: no · of votes cast
Bristol-Myers Squibb Company’s own tally for this item (“Item 5. The shareholder proposal on a Request to Cease DEI Efforts was not approved based upon the following votes:”): 26,455,925 for, 1,502,179,244 against, per its Form 8-K (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 2,042,071,247 outstanding shares: 1% for, 74% against (75% of the company cast a for/against vote).
The 3 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 187,847 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLENMEDE FUND INC | 0 | 146,947 | 0 | 0 | Against |
| Ultimus Managers Trust | 0 | 40,900 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Reported under meeting date 2026-03-12; no official results on file for that date.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (10,919,741 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 10,887,659 | 0 | 0 | 0 | For |
| Robertson Stephens Wealth Management, LLC | 32,082 | 0 | 0 | 0 | For |
Ranked by the number of Bristol-Myers Squibb Company shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 2,042,071,247 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 11.39% |
| 2 | Charles Schwab | 7.30% |
| 3 | BlackRock | 7.11% |
| 4 | Fidelity | 3.20% |
| 5 | State Street | 3.08% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.67% |
| 7 | JPMorgan | 2.08% |
| 8 | Invesco | 1.60% |
| 9 | PRIMECAP MANAGEMENT CO/CA/ | 1.22% |
| 10 | Capital Group | 1.00% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Vanguard Group | 9.73% | 13F |
| BlackRock | 8.41% | 13F |
| State Street | 4.83% | 13F |
| JPMorgan Chase | 4.53% | 13F |
| Charles Schwab | 2.99% | 13F |
| Morgan Stanley | 1.39% | 13F |
| Northern Trust | 1.21% | 13F |
| BNY Mellon | 1.14% | 13F |
Percentages above are of 2,042,071,247 shares outstanding, as reported by Bristol-Myers Squibb Company on its Form 10-Q dated 2026-04-21 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Bristol-Myers Squibb Company’s 10-Q dated 2026-04-21. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Bristol-Myers Squibb Company's shareholder meeting held 2026-05-05, in the 2025-2026 proxy season, 1,530 asset managers reported how they voted in their SEC Form N-PX filings, covering 21,015 separate fund positions. Their filings are grouped here into 35 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory Vote to Approve the Compensation of our Named Executive Officers — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Bristol-Myers Squibb Company's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).
Bristol-Myers Squibb Company proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).